Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEC90 of ropivacaine for axillary brachial plexus block with or without intravenous dexamethasone
2018-002482-18Phase 3Completed
- Sponsor
- CHU de Besançon
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial comparing Ropivacaine + intravenous dexamethasone with Ropivacaine + intravenous placebo (2 arms). Primary endpoint: Successful surgical anesthesia after axillary block. Started Jul 2018; status: completed.
02
Drugs
ropivacainedexamethasone
Beyond the preview
Go deeper on 2018-002482-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002482-18.